109 related articles for article (PubMed ID: 6580896)
1. Bromo-DMA: the Australasian hallucinogen?
Buhrich N; Morris G; Cook G
Aust N Z J Psychiatry; 1983 Sep; 17(3):275-9. PubMed ID: 6580896
[TBL] [Abstract][Full Text] [Related]
2. Bromo-DMA: new hallucinogenic drug.
Delliou D
Med J Aust; 1980 Jan; 1(2):83. PubMed ID: 7360100
[No Abstract] [Full Text] [Related]
3. Identification and quantitation of 4-bromo-2,5-dimethoxyamphetamine in seized blotters.
Burrai L; Nieddu M; Palomba M; Pirisi MA
Leg Med (Tokyo); 2015 Jan; 17(1):56-9. PubMed ID: 25248801
[TBL] [Abstract][Full Text] [Related]
4. Electrochemical study of the hallucinogen (+-)-1-(2,5-dimethoxy-4-nitrophenyl)-2-aminopropane.
Richter P; Morales A; Gómez-Jeria JS; Morales-Lagos D
Analyst; 1988 Jun; 113(6):859-63. PubMed ID: 3218759
[No Abstract] [Full Text] [Related]
5. Substituent branching in phenethylamine-type hallucinogens: a comparison of 1-[2,5-dimethoxy-4-(2-butyl)phenyl]-2-aminopropane and 1-[2,5-dimethoxy-4-(2-methylpropyl)phenyl]-2-aminopropane.
Oberlender RA; Kothari PJ; Nichols DE; Zabik JE
J Med Chem; 1984 Jun; 27(6):788-92. PubMed ID: 6737421
[TBL] [Abstract][Full Text] [Related]
6. A death due to 4-bromo-2,5-dimethoxyamphetamine.
Winek CL; Collom WD; Bricker JD
Clin Toxicol; 1981 Mar; 18(3):267-71. PubMed ID: 7237958
[No Abstract] [Full Text] [Related]
7. Management of hallucinogen abuse.
Haddad LM
Am Fam Physician; 1976 Jul; 14(1):82-7. PubMed ID: 1065215
[TBL] [Abstract][Full Text] [Related]
8. 4-bromo-2,5-dimethoxyamphetamine: psychoactivity, toxic effects and analytical methods.
Delliou D
Forensic Sci Int; 1983; 21(3):259-67. PubMed ID: 6873782
[TBL] [Abstract][Full Text] [Related]
9. LSD or DOB?
Davis WM
Am J Psychiatry; 1982 Dec; 139(12):1649. PubMed ID: 7149079
[No Abstract] [Full Text] [Related]
10. 4-Bromo-2,5-dimethoxyphenethylamine: identification of a new street drug.
Ragan FA; Hite SA; Samuels MS; Garey RE
J Anal Toxicol; 1985; 9(2):91-3. PubMed ID: 3990254
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the identification of psychotropic substances. VI. Preparation and various analytical data of reference standards of some hallucinogens, 2,5-dimethoxy-4-methylamphetamine (STP), 2,5-dimethoxy-4-bromoamphetamine (DOB) and 2,5-dimethoxy-4-ethylamphetamine (DOET)].
Shimamine M; Takahashi K; Nakahara Y
Eisei Shikenjo Hokoku; 1989; (107):113-9. PubMed ID: 2636911
[TBL] [Abstract][Full Text] [Related]
12. Isomeric cyclopropyl ring-methylated homologues of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, an hallucinogen analogue.
Jacob JN; Nichols DE
J Med Chem; 1982 May; 25(5):526-30. PubMed ID: 7086838
[TBL] [Abstract][Full Text] [Related]
13. The behavioral effects of 2,5-dimethoxy-4-alkyl amphetamines.
Morin RD; Benington F; Mitchell SR; Beaton JM; Bradley RJ; Smythies JR
Experientia; 1975 Jan; 31(1):93-5. PubMed ID: 234850
[No Abstract] [Full Text] [Related]
14. Nonfatal and fatal DOB (2,5-dimethoxy-4-bromoamphetamine) overdose.
Balíková M
Forensic Sci Int; 2005 Oct; 153(1):85-91. PubMed ID: 15979834
[TBL] [Abstract][Full Text] [Related]
15. Prolonged Psychosis With Catatonia due to 2,5-Dimethoxy-4-Bromoamphetamine: Case Report and Literature Review.
Scarella TM; Teslyar P
Psychosomatics; 2019; 60(6):599-602. PubMed ID: 30583875
[No Abstract] [Full Text] [Related]
16. Resolution and absolute configuration of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, a potent hallucinogen analogue.
Nichols DE; Woodard R; Hathaway BA; Lowy MT; Yom KW
J Med Chem; 1979 Apr; 22(4):458-60. PubMed ID: 430485
[TBL] [Abstract][Full Text] [Related]
17. A reevaluation of psychotomimetic amphetamine derivatives in humans.
Cassels BK; Gómez-Jeria JS
J Psychoactive Drugs; 1985; 17(2):129-30. PubMed ID: 4020537
[No Abstract] [Full Text] [Related]
18. A behavioral comparison of Nexus, cathinone, BDB, and MDA.
Bronson ME; Jiang W; DeRuiter J; Clark CR
Pharmacol Biochem Behav; 1995; 51(2-3):473-5. PubMed ID: 7667371
[TBL] [Abstract][Full Text] [Related]
19. Autoradiography of LSD and 2,5-dimethoxyphenylisopropylamine psychotomimetics demonstrates regional, specific cross-displacement in the rat brain.
McKenna DJ; Saavedra JM
Eur J Pharmacol; 1987 Oct; 142(2):313-5. PubMed ID: 3691644
[No Abstract] [Full Text] [Related]
20. Profiles of psychedelic drugs: 10. DOB.
Shulgin A
J Psychoactive Drugs; 1981; 13(1):99. PubMed ID: 7277091
[No Abstract] [Full Text] [Related]
[Next] [New Search]
